Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells
- PMID: 6385004
- PMCID: PMC391792
- DOI: 10.1073/pnas.81.18.5767
Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells
Abstract
The predominant gangliosides produced by two cultured human melanoma cell lines are GD3 and/or GD2. These gangliosides were found to be cell associated and present in substratum-attached material after cell removal by EDTA. Monoclonal antibodies directed to GD2 and GD3 specified the cell-surface distribution of these gangliosides and localized them in focal adhesion plaques at the interface of cells and their substratum. These attachment sites did not represent indiscriminant membrane fragments remaining after removal of cells with EDTA, because neither melanoma-associated proteoglycan nor class I histocompatibility antigens were detected by their respective antibodies. Our data suggest that the disialogangliosides GD2 and GD3 may be involved in the interaction between human melanoma cells and solid substrata.
Similar articles
-
An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2.J Cell Biol. 1987 Sep;105(3):1163-73. doi: 10.1083/jcb.105.3.1163. J Cell Biol. 1987. PMID: 2443507 Free PMC article.
-
Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.J Cell Biol. 1986 Mar;102(3):688-96. doi: 10.1083/jcb.102.3.688. J Cell Biol. 1986. PMID: 3005335 Free PMC article.
-
Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.Cancer Res. 1992 Sep 15;52(18):4948-53. Cancer Res. 1992. PMID: 1516051
-
Disialyl gangliosides enhance tumor phenotypes with differential modalities.Glycoconj J. 2012 Dec;29(8-9):579-84. doi: 10.1007/s10719-012-9423-0. Epub 2012 Jul 5. Glycoconj J. 2012. PMID: 22763744 Review.
-
The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.Front Cell Dev Biol. 2023 Feb 7;11:1076862. doi: 10.3389/fcell.2023.1076862. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36824365 Free PMC article. Review.
Cited by
-
Disialoganglioside GD2 distributes preferentially into substrate-associated microprocesses on human melanoma cells during their attachment to fibronectin.J Cell Biol. 1986 May;102(5):1887-97. doi: 10.1083/jcb.102.5.1887. J Cell Biol. 1986. PMID: 3084502 Free PMC article.
-
An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2.J Cell Biol. 1987 Sep;105(3):1163-73. doi: 10.1083/jcb.105.3.1163. J Cell Biol. 1987. PMID: 2443507 Free PMC article.
-
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy.Biologics. 2018 Dec 21;13:1-12. doi: 10.2147/BTT.S114530. eCollection 2019. Biologics. 2018. PMID: 30613134 Free PMC article. Review.
-
Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2805-9. doi: 10.1073/pnas.92.7.2805. Proc Natl Acad Sci U S A. 1995. PMID: 7708728 Free PMC article.
-
Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.Mol Ther. 2011 Jun;19(6):1131-40. doi: 10.1038/mt.2011.54. Epub 2011 Apr 12. Mol Ther. 2011. PMID: 21487394 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical